Illumina, Inc. introduced three early-access capabilities on its BioInsight Platform that help researchers move faster from sequencing data to discovery. BioInsight Platform Workflow Orchestrator ...
Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...
Illumina, Inc. (NASDAQ: ILMN) today introduced three early-access capabilities on its BioInsight Platform that help ...
Major Products Selected by PurposeOct 21, 2026[PR] This article was written by Freely Tech Inc., the provider of the SES ...
Software, genome sequencing, drug discovery and cloud platforms lead adoption, while precision medicine, diagnostics and AI-enabled services create new opportunities.Dublin, Oct. 19, 2026 (GLOBE ...
Element Biosciences, Inc. today announced the first shipment of Cytos™, a first-of-its-kind multiomics workflow that captures guide RNA, cell morphology, protein expression, and whole transcriptome ...